A transfeminine patient with localized prostate cancer opted for orchiectomy for both gender affirmation and androgen deprivation therapy, and a trans man with BRCA2 mutated breast cancer chose bilateral mastectomy, hysterectomy, and salpingo-oophorectomy. This evidence concerns the gene BRCA2 and breast carcinoma.